Page last updated: 2024-08-24

carbogen and carboplatin

carbogen has been researched along with carboplatin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bubley, G; Coleman, CN; Eder, JP; Frei, E; Herman, TS; Holden, SA; Tanaka, J; Teicher, BA	1
Artazkoz, JJ; Borque, C; Cabezon, MA; de Serdio, JL; Espiñeira, M; Fuentes, C; Gil, J; Martinez, JC; Perez, MD; Saavedra, JA; Suñer, M; Villar, A	1
de Serdio, JL; Martinez, JC; Villar, A	1

Trials

1 trial(s) available for carbogen and carboplatin

Article	Year
Hyperfractionated chemoradiation with carbogen breathing, with or without erythropoietin: a stepwise developed treatment schedule for advanced head-and-neck cancer. International journal of radiation oncology, biology, physics, 2001, May-01, Volume: 50, Issue:1 Topics: Administration, Inhalation; Adult; Aged; Anemia; Antineoplastic Agents; Carbon Dioxide; Carboplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Erythrocyte Transfusion; Erythropoietin; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oxygen; Radiation-Sensitizing Agents; Survival Rate	2001

Article

Year

Hyperfractionated chemoradiation with carbogen breathing, with or without erythropoietin: a stepwise developed treatment schedule for advanced head-and-neck cancer.

International journal of radiation oncology, biology, physics, 2001, May-01, Volume: 50, Issue:1

Topics: Administration, Inhalation; Adult; Aged; Anemia; Antineoplastic Agents; Carbon Dioxide; Carboplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Erythrocyte Transfusion; Erythropoietin; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oxygen; Radiation-Sensitizing Agents; Survival Rate

2001

Other Studies

2 other study(ies) available for carbogen and carboplatin

Article	Year
Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma. Cancer research, 1991, Feb-15, Volume: 51, Issue:4 Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carbon Dioxide; Carboplatin; Carmustine; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Etanidazole; Fibrosarcoma; Flow Cytometry; Fluorocarbons; Hydroxyethyl Starch Derivatives; Mammary Neoplasms, Experimental; Melphalan; Mice; Nitroimidazoles; Organoplatinum Compounds; Oxygen; Radiation-Sensitizing Agents; Thiotepa	1991
Chemoradiation for advanced head and neck cancer: potential for improving results to match those of current treatment modalities for early-stage tumors--long-term results of hyperfractionated chemoradiation with carbogen breathing and anemia correction wi International journal of radiation oncology, biology, physics, 2008, Apr-01, Volume: 70, Issue:5 Topics: Administration, Inhalation; Adult; Aged; Anemia; Antineoplastic Agents; Carbon Dioxide; Carboplatin; Carcinoma, Squamous Cell; Clinical Protocols; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Erythropoietin; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oxygen; Radiation Injuries; Radiation-Sensitizing Agents; Recombinant Proteins; Salvage Therapy	2008

Article

Year

Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.

Cancer research, 1991, Feb-15, Volume: 51, Issue:4

Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carbon Dioxide; Carboplatin; Carmustine; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Etanidazole; Fibrosarcoma; Flow Cytometry; Fluorocarbons; Hydroxyethyl Starch Derivatives; Mammary Neoplasms, Experimental; Melphalan; Mice; Nitroimidazoles; Organoplatinum Compounds; Oxygen; Radiation-Sensitizing Agents; Thiotepa

1991

Chemoradiation for advanced head and neck cancer: potential for improving results to match those of current treatment modalities for early-stage tumors--long-term results of hyperfractionated chemoradiation with carbogen breathing and anemia correction wi

International journal of radiation oncology, biology, physics, 2008, Apr-01, Volume: 70, Issue:5

Topics: Administration, Inhalation; Adult; Aged; Anemia; Antineoplastic Agents; Carbon Dioxide; Carboplatin; Carcinoma, Squamous Cell; Clinical Protocols; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Erythropoietin; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oxygen; Radiation Injuries; Radiation-Sensitizing Agents; Recombinant Proteins; Salvage Therapy

2008